Taken together, our findings demonstrated that overexpression of PCGEM1 potentiatedthe anti-inflammatory effect of montelukast sodium and promotive effect on pulmonaryfunction, which highlights a novel therapeutic approach for children with CVA. Here, PCGEM1 is linked to stroke disorder.